As Long as Brand Patents Continue to Expire, Pharmaceutical Companies Will Continue to Challenge Generic Entrants with 'New and Improved' Versions of Existing Products.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c31416) has announced the addition of Defending Brand Revenue: Pharmaceutical Lifecycle Management Planning to their offering. Developing lifecycle management strategies to maximize In a graphical environment, to enlarge a window to the full size of the screen. See Win Maximize windows. branded drugs' profitability is a key strategy for the pharmaceutical industry. Aside from defending against generic Generic Describes the characteristics and/or experience of the total universe of a coupon of MBS sector type; that is, in contrast to a specific pool or collateral group, as in a specific CMO issue. competition, lifecycle management strategies enable companies to sustain their revenue streams and fill gaps in their pipelines as increasing numbers of key brands begin to lose patent protection. Line extensions, patent protection and post-Launch promotional strategies represent a new approach to marketing and protecting market share. No matter what options the brand team adopts, lifecycle management tactics grant an additional protection against incoming Incoming is a 3-D shooter developed by Rage Software and published by Interplay. The PC version was released in late 1998, and the Dreamcast version, a launch title for the console, was released in 1998 in Japan and in 1999 in the rest of the world. competition. Extending a brand's lifecycle through additional line extensions or launching new promotional strategies has become a vital means of exploiting a brand's long-established equity. As long as brand patents continue to expire expire /ex·pire/ (ek-spi´er) 1. to exhale. 2. to die. ex·pire v. 1. To breathe one's last breath; die. 2. To exhale. , pharmaceutical companies will continue to challenge generic entrants with "new and improved" versions of existing products. Companies Mentioned: Abbott Laboratories Alza Amgen AstraZeneca Axcan Pharma Bayer Biogen Idec BMS Eli Lilly Endo Pharmaceutical Genentech GlaxoSmithKline Janssen-Cilag King Pharmaceuticals Merck Novartis Pfizer Sanofi-Aventis Schering-Plough Terumo Penpol Wyeth For more information visit http://www.researchandmarkets.com/reports/c31416 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion